TGA Rescheduling Mind Medicine Australia The Therapeutic Goods Administration has issued a safety warning, saying it's "concerned" about an increase in the importation and supply of unapproved peptides. Safety advisory Understanding your responsibilities when importing, compounding and supplying unapproved peptide products We are concerned about the rise in the import, supply, compounding and advertising of unapproved peptide products Scheduling handbook: Guidance for amending the Poisons Standard Therapeutic Goods Administration (TGA)